News

Genomic Medicine Sweden and Danish National Genome Center in partnership to advance precision medicine

29 April, 2022 | Press release

Genomic Medicine Sweden and the Danish National Genome Center has signed an agreement with the aim to advance genomics and precision medicine and its implementation in healthcare. The joint partnership will focus on the development and implementation of innovative...

Sequencing of 7,000 genomes in Swedish clinical practice in 2021 for better diagnosis and treatment

11 April, 2022 | News

In 2021, analyzes were performed of 5,000 samples with whole genome sequencing and almost 2,000 samples with whole exome sequencing in clinical routine in Sweden. The majority of these analyzes were performed for the diagnosis of patients with rare diseases. In...

The legal room for sharing genetic data for the purpose of providing care for others is limited

5 April, 2022 | News

There are currently no legal opportunities for the healthcare regions to, on a large scale, access the genetic data of patients in other regions for the purpose of providing better and more equal care for patients all across Sweden. This is shown in a new report by...

GMS and Centers for Personalized Medicine in Germany in new collaboration in precision medicine

22 February, 2022 | News

Genomic Medicine Sweden (GMS) and Centers for Personalized Medicine (ZPM) in Germany, one of Europe’s leading centers in personalized medicine, will intensify the collaboration between the two organizations under the joint Memorandum of Understanding (MoU). The MoU...

Targeted treatment helped child with neuroblastoma

2 February, 2022 | News

Researchers at Karolinska Institutet and the University of Gothenburg have found another piece of the puzzle in the treatment of the childhood cancer neuroblastoma. A new case report, published in JCO Precision Oncology, describes the successful targeted treatment of...

GMS and France Genomic Medicine Initiative partnership in precision medicine

14 October, 2021 | News

On October 14th, the Director and CEO for the French National Alliance for Life Sciences and Health, Gilles Bloch, visited Genomic Medicine Sweden, hosted by Karolinska Institutet´s President Ole Petter Ottersen. During the visit Gilles Bloch, Director of the French...

Sweden launches testbed for clinical trials in cancer care

24 September, 2021 | News

Vision Zero Cancer and Genomic Medicine Sweden (GMS) join forces with SciLifeLab, public sector authorities, regions, healthcare, academia, industry and patient organizations to create an innovation milieu that facilitates the introduction of more precise prevention...

Significant nationwide investment in precision medicine

16 September, 2021 | Press release

The Swedish national infrastructure Genomic Medicine Sweden (GMS) will receive an additional SEK 220 million investment. The investment will facilitate the continued introduction of precision medicine into Swedish healthcare, so that every individual in Sweden has...

Precision medicine new opportunity for complex diseases

5 July, 2021 | News

New review article looks at readiness prior to the implementation of genomics-based precision medicine in complex diseases. The extensive work has been led by researchers at Karolinska Institutet and Lund University and has been carried out together with some 30...

Common lessons learned from the start-up of precision medicine initiatives

30 June, 2021 | News

Over recent years, a large number of national and regional initiatives in the field of precision medicine have been established in Europe. In an overview published in Seminars in Cancer Biology, Genomic Medicine Sweden (GMS) and Centers for Personalized Medicine (ZPM)...

Arkiv

Val av samtycke till kakor